1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
(
- Contribution to journal › Article
-
Mark
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
(
- Contribution to journal › Article
- 2020
-
Mark
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
(
- Contribution to journal › Article
-
Mark
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
(
- Contribution to journal › Article
-
Mark
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
(
- Contribution to journal › Article
- 2019
-
Mark
Genome-wide association study of germline variants and breast cancer-specific mortality
(
- Contribution to journal › Article
-
Mark
Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors : an international survey
(
- Contribution to journal › Article
- 2016
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
-
Mark
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
(
- Contribution to journal › Article
-
Mark
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
(
- Contribution to journal › Article